
    
      To determine the efficacy of AzA foam, 15% compared to vehicle topically applied twice daily
      in papulopustular rosacea evaluated by therapeutic success rate according to Investigators
      Global Assessment (IGA) and change in inflammatory lesion count from baseline to end of
      treatment.

      Evaluation of all adverse events will be covered in Adverse Events section.
    
  